ATE136901T1 - Antigen gegen diabetes - Google Patents
Antigen gegen diabetesInfo
- Publication number
- ATE136901T1 ATE136901T1 AT89902951T AT89902951T ATE136901T1 AT E136901 T1 ATE136901 T1 AT E136901T1 AT 89902951 T AT89902951 T AT 89902951T AT 89902951 T AT89902951 T AT 89902951T AT E136901 T1 ATE136901 T1 AT E136901T1
- Authority
- AT
- Austria
- Prior art keywords
- cell
- species
- antigen against
- against diabetes
- somatic cell
- Prior art date
Links
- 239000000427 antigen Substances 0.000 title 1
- 102000036639 antigens Human genes 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 206010012601 diabetes mellitus Diseases 0.000 title 1
- 210000004027 cell Anatomy 0.000 abstract 2
- 210000001082 somatic cell Anatomy 0.000 abstract 2
- 208000023275 Autoimmune disease Diseases 0.000 abstract 1
- 230000000890 antigenic effect Effects 0.000 abstract 1
- 210000004754 hybrid cell Anatomy 0.000 abstract 1
- 230000003248 secreting effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
- A61K47/6843—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a material from animals or humans
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Rheumatology (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Steroid Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB888803757A GB8803757D0 (en) | 1988-02-18 | 1988-02-18 | Antigens against autoimmune diseases |
| GB888803756A GB8803756D0 (en) | 1988-02-18 | 1988-02-18 | Hybrid cells for producing biological products |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE136901T1 true ATE136901T1 (de) | 1996-05-15 |
Family
ID=26293506
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT89902951T ATE136901T1 (de) | 1988-02-18 | 1989-02-15 | Antigen gegen diabetes |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP0401271B1 (de) |
| JP (1) | JPH03502795A (de) |
| AT (1) | ATE136901T1 (de) |
| DE (1) | DE68926294T2 (de) |
| WO (1) | WO1989007601A1 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5776093A (en) | 1985-07-05 | 1998-07-07 | Immunomedics, Inc. | Method for imaging and treating organs and tissues |
| SE9402090D0 (sv) * | 1994-06-14 | 1994-06-14 | Rudolf Valenta | Recombinent molecules, proteins/polypeptides, host systems and diagnostic and therapeutic methods for atopy |
| AU5744800A (en) * | 1999-06-16 | 2001-01-02 | Biocrystal Limited | Vaccine formulations and methods for immunizing an individual against shed antigen-specific b cells |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL69686A (en) * | 1983-09-11 | 1988-03-31 | Yeda Res & Dev | Compositions containing cell membrane proteins and process for their preparation |
| EP0155676A3 (de) * | 1984-03-19 | 1988-02-24 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Verfahren zur Gewinnung der globulären Domäne von Basalmembrankollagen und immunologische Bestimmung von Basalmembranmaterial und Autoantikörpern |
| WO1987005929A1 (en) * | 1986-04-01 | 1987-10-08 | Genelabs Incorporated | Immortalized cells which produce tissue-specific products |
| ZA874410B (en) * | 1986-06-24 | 1988-04-27 | Merrell Dow Pharma | Fusion products |
-
1989
- 1989-02-15 EP EP89902951A patent/EP0401271B1/de not_active Expired - Lifetime
- 1989-02-15 WO PCT/GB1989/000138 patent/WO1989007601A1/en not_active Ceased
- 1989-02-15 DE DE68926294T patent/DE68926294T2/de not_active Expired - Fee Related
- 1989-02-15 JP JP1502736A patent/JPH03502795A/ja active Pending
- 1989-02-15 AT AT89902951T patent/ATE136901T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DE68926294T2 (de) | 1996-09-19 |
| JPH03502795A (ja) | 1991-06-27 |
| EP0401271A1 (de) | 1990-12-12 |
| WO1989007601A1 (en) | 1989-08-24 |
| EP0401271B1 (de) | 1996-04-17 |
| DE68926294D1 (de) | 1996-05-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE13317T1 (de) | Hybridzellinie zur herstellung monoklonaler antikoerper gegen ein menschliches prothymozytantigen; antikoerper und verfahren zu seiner herstellung; diagnostische und therapeutische verwendungen und diesen antikoerper enthaltende pharmazeutische zusammensetzungen. | |
| IL59919A0 (en) | A monoclonal antibody of class lgg,its preparation and pharmaceutical compositions containing it | |
| DK609985A (da) | Adhesin-antigener, antistoffer mod disse og dna-fragmenter, som indkoder antigenerne | |
| ES531986A0 (es) | Un metodo de producir una forma geneticamente estable de vidrio cholerae | |
| ATE13198T1 (de) | Hybridzellinie zur herstellung monoklonaler antikoerper gegen ein menschliches t-zellenantigen, antikoerper und verfahren. | |
| DE69426564D1 (de) | Herstellung und verwendung von transgenen mäusen mit fehlender expression von cd28 | |
| NO159882C (no) | Monoklonalt antistoff. | |
| NO159887C (no) | Monoklonalt antistoff. | |
| NO883362L (no) | Fremgangsmaate for gjenanvendelse av silisiumbasismateriale anvendt for solceller. | |
| ES497423A0 (es) | Un anticuerpo monoclonico | |
| DE68926294D1 (de) | Antigen gegen diabetes | |
| DE3854267D1 (de) | HIV-spezifische monoklonale Antikörper und Hybridome zu ihrer Herstellung. | |
| ATE109004T1 (de) | Toleranzinduktion gegenüber einem fremdantigen. | |
| ES2101694T3 (es) | Expresion de edulcorantes proteinicos en levadura. | |
| IT7967442A0 (it) | Procedimento e dispositivo per la fabbricazione dei recipienti isolanti a doppia parete particolarmente di vetro | |
| GB8823081D0 (en) | Human monoclonal antibodies specifically recognizing rabies virus cells cells producing the same formulations containing the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |